U.S. federal trademark · Serial No. 97581122 · Reg. No. 7100849
Medical laboratory testing services for diagnostic or treatment purposes that enables DNAbased nextgeneration sequencing (NGS) testing to detect lymphoproliferative disorders and serve as molecular markers of malignant B or T cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.